# Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia

> **NCT00867672** · PHASE2 · COMPLETED · sponsor: **University Hospital Freiburg** · enrollment: 204 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Decitabine
- **DRUG:** VPA
- **DRUG:** ATRA

## Key facts

- **NCT ID:** NCT00867672
- **Lead sponsor:** University Hospital Freiburg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2015-02
- **Final completion:** 2016-02
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2016-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00867672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00867672, "Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00867672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*